105 related articles for article (PubMed ID: 10774586)
1. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
Jashés M; Mlynarz G; De Clercq E; Sandino AM
Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
[TBL] [Abstract][Full Text] [Related]
2. In vivo effect of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-carboxamide) on experimental infected rainbow trout (Oncorhynchus mykiss) and coho salmon (Oncorhynchus kisutch) fry with infectious pancreatic necrosis virus.
Moya J; Pizarro H; Jashés M; De Clercq E; Sandino AM
Antiviral Res; 2000 Nov; 48(2):125-30. PubMed ID: 11114414
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
Jashés M; González M; López-Lastra M; De Clercq E; Sandino A
Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of mycophenolic acid on the replication of infectious pancreatic necrosis virus and viral hemorrhagic septicemia virus.
Marroquí L; Estepa A; Perez L
Antiviral Res; 2008 Dec; 80(3):332-8. PubMed ID: 18721827
[TBL] [Abstract][Full Text] [Related]
5. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A
Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of aromatic geranyl derivatives isolated from Heliotropium filifolium on infectious pancreatic necrosis virus replication.
Modak B; Sandino AM; Arata L; Cárdenas-Jirón G; Torres R
Vet Microbiol; 2010 Feb; 141(1-2):53-8. PubMed ID: 19818567
[TBL] [Abstract][Full Text] [Related]
8. The interplay between infectious pancreatic necrosis virus (IPNV) and the IFN system: IFN signaling is inhibited by IPNV infection.
Skjesol A; Aamo T; Hegseth MN; Robertsen B; Jørgensen JB
Virus Res; 2009 Jul; 143(1):53-60. PubMed ID: 19463721
[TBL] [Abstract][Full Text] [Related]
9. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
Balzarini J; Lee CK; Schols D; De Clercq E
Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein.
Larsen R; Røkenes TP; Robertsen B
J Virol; 2004 Aug; 78(15):7938-44. PubMed ID: 15254166
[TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
[TBL] [Abstract][Full Text] [Related]
12. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
[TBL] [Abstract][Full Text] [Related]
14. Effect of ribavirin on the replication of infectious pancreatic necrosis virus in fish cell cultures.
Migus DO; Dobos P
J Gen Virol; 1980 Mar; 47(1):47-57. PubMed ID: 7365468
[TBL] [Abstract][Full Text] [Related]
15. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents.
Okano Y; Saito-Tarashima N; Kurosawa M; Iwabu A; Ota M; Watanabe T; Kato F; Hishiki T; Fujimuro M; Minakawa N
Bioorg Med Chem; 2019 Jun; 27(11):2181-2186. PubMed ID: 31003866
[TBL] [Abstract][Full Text] [Related]
18. Interferon mediated antiviral activity against salmonid fish viruses in BF-2 and other cell lines.
Saint-Jean SR; Pérez-Prieto SI
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):1-10. PubMed ID: 16169598
[TBL] [Abstract][Full Text] [Related]
19. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
Leyssen P; De Clercq E; Neyts J
Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Minakawa N; Matsuda A
Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
